Late gadolinium enhancement and the diagnosis of arrhythmogenic right ventricular cardiomyopathy.
作者信息
Bluemke David A
机构信息
Department of Radiology, The University of Wisconsin-Madison, 600 Highland Avenue, Madison, WI 53792, USA.
出版信息
J Cardiovasc Magn Reson. 2024;26(2):101075. doi: 10.1016/j.jocmr.2024.101075. Epub 2024 Jul 31.
Abstract
摘要
相似文献
1
Late gadolinium enhancement and the diagnosis of arrhythmogenic right ventricular cardiomyopathy.钆延迟强化与致心律失常性右室心肌病的诊断
J Cardiovasc Magn Reson. 2024;26(2):101075. doi: 10.1016/j.jocmr.2024.101075. Epub 2024 Jul 31.
2
[Arrhythmogenic cardiomyopathy. Patterns of ventricular involvement using cardiac magnetic resonance].[致心律失常性心肌病。利用心脏磁共振成像观察心室受累模式]
Rev Esp Cardiol. 2011 Dec;64(12):1114-22. doi: 10.1016/j.recesp.2011.07.014. Epub 2011 Oct 24.
3
Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.桥粒斑蛋白心肌病，一种与典型扩张型或致心律失常性右室心肌病不同的纤维性和炎症性心肌病。
Circulation. 2020 Jun 9;141(23):1872-1884. doi: 10.1161/CIRCULATIONAHA.119.044934. Epub 2020 May 6.
4
Cardiac MRI and Clinical Outcomes in Arrhythmogenic Cardiomyopathy.心律失常性心肌病的心脏 MRI 与临床结局。
Radiol Cardiothorac Imaging. 2023 Dec;5(6):e230155. doi: 10.1148/ryct.230155.
5
Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.心脏磁共振成像的区域性应变与多模态瘢痕评估中的晚期钆增强相比，可提高心律失常性右心室心肌病患者右心室瘢痕的检出率。
Circ Cardiovasc Imaging. 2018 Sep;11(9):e007546. doi: 10.1161/CIRCIMAGING.118.007546.
6
Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy: Combining Genetic and Histopathologic Findings.心律失常性左室心肌病患者的特征：结合遗传学和组织病理学发现。
Circ Arrhythm Electrophysiol. 2020 Dec;13(12):e009005. doi: 10.1161/CIRCEP.120.009005. Epub 2020 Dec 15.
7
Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy.心律失常性心肌病的诊断标准不断演变。
J Am Heart Assoc. 2021 Sep 21;10(18):e021987. doi: 10.1161/JAHA.121.021987. Epub 2021 Sep 17.
8
Utilization of sacubitril-valsartan for right ventricular failure in a patient with arrhythmogenic right ventricular cardiomyopathy.沙库巴曲缬沙坦在心律失常性右室心肌病患者右心衰竭中的应用。
Future Cardiol. 2022 Jul;18(7):547-552. doi: 10.2217/fca-2021-0148. Epub 2022 Jun 15.
9
Electrical and Structural Substrate of Arrhythmogenic Right Ventricular Cardiomyopathy Determined Using Noninvasive Electrocardiographic Imaging and Late Gadolinium Magnetic Resonance Imaging.使用无创心电图成像和钆延迟磁共振成像确定致心律失常性右室心肌病的电学和结构基质
Circ Arrhythm Electrophysiol. 2017 Jul;10(7). doi: 10.1161/CIRCEP.116.005105.
10
Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: Implications for ventricular tachycardia ablation.心律失常性右室心肌病患者心脏磁共振上区域性心外膜右心室电图电压幅度和延迟钆增强分布的相关性：对室性心动过速消融的影响。
Heart Rhythm. 2018 Jul;15(7):987-993. doi: 10.1016/j.hrthm.2018.02.030. Epub 2018 Mar 2.
本文引用的文献
1
Diagnostic value of late gadolinium enhancement at cardiovascular magnetic resonance to distinguish arrhythmogenic right ventricular cardiomyopathy from differentials.心血管磁共振延迟钆增强对鉴别致心律失常性右室心肌病与其他疾病的诊断价值
J Cardiovasc Magn Reson. 2024;26(2):101059. doi: 10.1016/j.jocmr.2024.101059. Epub 2024 Jul 8.
2
The Specificity of Left Ventricular Bite-Like Fibrofatty Replacement for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy.左心室咬痕样纤维脂肪替代物对致心律失常性右心室心肌病诊断的特异性
JACC Cardiovasc Imaging. 2024 Sep;17(9):1113-1115. doi: 10.1016/j.jcmg.2024.03.011. Epub 2024 May 8.
3
Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria.心律失常性心肌病的诊断：帕多瓦标准。
Int J Cardiol. 2020 Nov 15;319:106-114. doi: 10.1016/j.ijcard.2020.06.005. Epub 2020 Jun 16.
4
Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De Novo.致心律失常性右心室心肌病相关桥粒变异很少是新生的。
Circ Genom Precis Med. 2019 Aug;12(8):e002467. doi: 10.1161/CIRCGEN.119.002467. Epub 2019 Aug 6.
5
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.2019 HRS 专家共识声明：心律失常性心肌病的评估、风险分层和管理。
Heart Rhythm. 2019 Nov;16(11):e301-e372. doi: 10.1016/j.hrthm.2019.05.007. Epub 2019 May 9.
6
Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy.致心律失常性右室心肌病的遗传学及发病机制
Biophys Rev. 2018 Aug;10(4):973-982. doi: 10.1007/s12551-018-0437-0. Epub 2018 Jul 11.
7
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.致心律失常性右室心肌病/发育不良的诊断：工作组标准的拟议修改。
Eur Heart J. 2010 Apr;31(7):806-14. doi: 10.1093/eurheartj/ehq025. Epub 2010 Feb 19.
8
Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study.致心律失常性右室心肌病/发育异常的临床表现及诊断评估：北美多学科研究结果
Heart Rhythm. 2009 Jul;6(7):984-92. doi: 10.1016/j.hrthm.2009.03.013. Epub 2009 Mar 11.
9
Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity.左优势型致心律失常性心肌病：一种未被充分认识的临床实体。
J Am Coll Cardiol. 2008 Dec 16;52(25):2175-87. doi: 10.1016/j.jacc.2008.09.019.
10
Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.心肌病的当代定义和分类：美国心脏协会临床心脏病学理事会、心力衰竭与移植委员会的科学声明；医疗质量与结果研究及功能基因组学与转化生物学跨学科工作组；以及流行病学与预防理事会。
Circulation. 2006 Apr 11;113(14):1807-16. doi: 10.1161/CIRCULATIONAHA.106.174287. Epub 2006 Mar 27.
Zotero 插件